| ALP | Alkaline phosphatase |
| AR | Androgen receptor |
| BMC | Bone mineral content |
| BMD | Bone mineral density |
| BMP | Bone morphogenetic protein |
| CTP | Pyridinoline cross-linked carboxyterminal telopeptide |
| CXCL1 | C-X-C motif chemokine ligand 1 |
| CXCL5 | C-X-C motif chemokine ligand 5 |
| EGFR | Epidermal growth factor receptor |
| ERα | Estrogen receptor-alpha |
| ERBB2 | Erb-B2 receptor tyrosine kinase 2 |
| ET-1 | Endothelin-1 |
| ETAR | Endothelin-A receptor |
| FDA | Food and Drug Administration |
| FGF | Fibroblast growth factor |
| GDF15 | Growth differentiation factor 15 |
| HGF | Hepatocyte growth factor |
| HGFR | Hepatocyte growth factor receptor |
| IGF | Insulin-like growth factor |
| IL-8 | Interleukin-8 |
| MAPK | Mitogen-activated protein kinase |
| MCP-1 | Monocyte chemotactic protein-1 |
| M-CSF | Macrophage-colony stimulating factors |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| OCN | Osteocalcin |
| OHS | Osteoblast-derived sarcoma cells |
| OPG | Osteoprotegerin |
| PSA | Prostate-specific antigen |
| PTH | Parathyroid hormone |
| PTHrP | Parathyroid hormone-related peptide |
| RANK | Receptor activator of nuclear factor-kappa B |
| RANKL | Receptor activator of nuclear factor-kappa B ligand |
| Runx2 | Runt-related transcription factor 2 |
| SCID | Severe combined immunodeficient |
| Sema 3A | Semaphorin 3A |
| STAT3 | Signal transducer and activator of transcription 3 |
| TGF-β | Transforming growth factor-beta |
| TRAP | Tartrate-resistant acid phosphatase |
| VEGF-A | Vascular endothelial growth factor-A |
| VEGFR2 | Vascular endothelial growth factor receptor 2 |
| Wnt | Wingless |